{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T08:17:28Z","timestamp":1765959448309},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Rheumatol"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1038\/ncprheum0484","type":"journal-article","created":{"date-parts":[[2007,4,30]],"date-time":"2007-04-30T16:43:20Z","timestamp":1177951400000},"page":"273-281","source":"Crossref","is-referenced-by-count":30,"title":["Therapy Insight: guidelines for selection of contraception in women with rheumatic diseases"],"prefix":"10.1038","volume":"3","author":[{"given":"Lisa R","family":"Sammaritano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BFncprheum0484_CR1","unstructured":"Family planning, contraception, sterilization and pregnancy termination (2001) In: Comprehensive Gynecology, edn 4, 295\u2013358 (Eds Stenchever MA  et al.) St. Louis: Mosby, Inc."},{"key":"BFncprheum0484_CR2","first-page":"553","volume-title":"Danforth's Obstetrics and Gynecology","author":"RA Chez","year":"1999","unstructured":"Chez RA and Strathman I (1999) Contraception and Sterilization. In: Danforth's Obstetrics and Gynecology, 553\u2013566 (Eds JR Scott  et al.) Philadelphia: Lippincott, Williams and Wilkins"},{"key":"BFncprheum0484_CR3","unstructured":"World Health Organization (2004) Medical eligibility criteria for contraceptive use (Third edition) [\n                    http:\/\/www.who.int\/reproductive-health\/publications\/mec\/index.htm\n                    \n                  ] (accessed July 13, 2006)"},{"key":"BFncprheum0484_CR4","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.ajog.2004.12.091","volume":"192","author":"AM Kaunitz","year":"2005","unstructured":"Kaunitz AM (2005) Beyond the pill: new data and options in hormonal and intrauterine contraception. Am J Obstet Gynecol 192: 998\u20131004","journal-title":"Am J Obstet Gynecol"},{"key":"BFncprheum0484_CR5","doi-asserted-by":"crossref","unstructured":"The Practice Committee of the American Society for Reproductive Medicine (2004) Hormonal contraception: recent advances and controversies. Fertil Steril 82: 520\u2013526","DOI":"10.1016\/j.fertnstert.2004.03.019"},{"key":"BFncprheum0484_CR6","first-page":"853","volume":"69","author":"EJ Herndon","year":"2004","unstructured":"Herndon EJ and Zieman M (2004) New contraceptive options. Am Fam Physician 69: 853\u2013860","journal-title":"Am Fam Physician"},{"key":"BFncprheum0484_CR7","unstructured":"U.S. Food and Drug Administration (2005) Safety alert: Ortho Evra (posted 11\/14\/2005) [\n                    http:\/\/www.fda.gov\/medwatch\/SAFETY\/2005\/safety05.htm\n                    \n                  ] (accessed July 13, 2006)"},{"key":"BFncprheum0484_CR8","first-page":"97","volume":"26","author":"A Bigrigg","year":"2000","unstructured":"Bigrigg A  et al. (2000) Depo Provera. Discussion paper on clinical use, effectiveness and side effects. Br J Fam Plann 26: 97\u201399","journal-title":"Br J Fam Plann"},{"key":"BFncprheum0484_CR9","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1136\/bmj.308.6923.247","volume":"308","author":"T Cundy","year":"1994","unstructured":"Cundy T  et al. (1994) Recovery of bone density in women who stop using medroxyprogesterone acetate. BMJ 308: 247\u2013248","journal-title":"BMJ"},{"key":"BFncprheum0484_CR10","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1016\/j.ajog.2004.01.061","volume":"190","author":"R Burkman","year":"2004","unstructured":"Burkman R  et al. (2004) Safety concerns and health benefits associated with oral contraception. Am J Obstet Gynecol 190: S5\u2013S22","journal-title":"Am J Obstet Gynecol"},{"key":"BFncprheum0484_CR11","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/S0140-6736(02)08150-3","volume":"359","author":"V Moreno","year":"2002","unstructured":"Moreno V  et al. (2002) Effect of oral contraceptives on risk of cervical cancer in women with human papilloma virus infection: the IARC multicentric case\u2013control study. Lancet 359: 1085\u20131092","journal-title":"Lancet"},{"key":"BFncprheum0484_CR12","doi-asserted-by":"crossref","unstructured":"Collaborative Group on Hormonal Factors in Breast Cancer (1996) Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53,297 women with breast cancer and 100,239 women without breast cancer from 54 epidemiological studies. Lancet 347: 1713\u20131727","DOI":"10.1016\/S0140-6736(96)90806-5"},{"key":"BFncprheum0484_CR13","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1055\/s-0037-1616237","volume":"86","author":"I Martinelli","year":"2001","unstructured":"Martinelli I (2001) Risk factors in venous thromboembolism. Thromb Haemost 86: 395\u2013403","journal-title":"Thromb Haemost"},{"key":"BFncprheum0484_CR14","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1093\/oxfordjournals.aje.a115799","volume":"133","author":"BB Gerstman","year":"1991","unstructured":"Gerstman BB  et al. (1991) Oral contraceptive estrogen dose and the risk of venous thromboembolic disease. Am J Epidemiol 133: 32\u201337","journal-title":"Am J Epidemiol"},{"key":"BFncprheum0484_CR15","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1136\/bmj.323.7305.131","volume":"323","author":"JM Kemmeren","year":"2001","unstructured":"Kemmeren JM  et al. (2001) Third generation oral contraceptives and risk of venous thrombosis: meta-analysis. BMJ 323: 131\u2013134","journal-title":"BMJ"},{"key":"BFncprheum0484_CR16","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0301-2115(00)00489-9","volume":"95","author":"J Rosing","year":"2001","unstructured":"Rosing J  et al. (2001) Oral contraceptives, thrombosis, and hemostasis. Eur J Obstet Gynecol Reprod Biol 95: 193\u2013197","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"BFncprheum0484_CR17","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0010-7824(01)00307-9","volume":"65","author":"O Lidegaard","year":"2002","unstructured":"Lidegaard O  et al. (2002) Oral contraceptives and venous thromboembolism: a five-year national case\u2013control study. Contraception 65: 187\u2013196","journal-title":"Contraception"},{"key":"BFncprheum0484_CR18","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1023\/B:THRO.0000003323.80742.4d","volume":"15","author":"D Voora","year":"2003","unstructured":"Voora D and Vijayan A (2003) Mesenteric vein thrombosis associated with intravaginal contraceptives: a case report and review of the literature. J Thromb Thrombolysis 15: 105\u2013108","journal-title":"J Thromb Thrombolysis"},{"key":"BFncprheum0484_CR19","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1055\/s-0037-1613379","volume":"89","author":"M Abdollahi","year":"2003","unstructured":"Abdollahi M  et al. (2003) Obesity: risk of venous thrombosis and the interaction of coagulation factor levels and oral contraceptives. Thromb Haemost 89: 493\u2013498","journal-title":"Thromb Haemost"},{"key":"BFncprheum0484_CR20","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1161\/01.STR.0000015345.61324.3F","volume":"33","author":"JM Kemmeren","year":"2002","unstructured":"Kemmeren JM  et al. (2002) Risk of Arterial Thrombosis in Relation to Oral Contraceptives (RATIO) study: oral contraceptives and the risk of ischemic stroke. Stroke 33: 1202\u20131208","journal-title":"Stroke"},{"key":"BFncprheum0484_CR21","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1056\/NEJMoa003216","volume":"345","author":"BC Tanis","year":"2001","unstructured":"Tanis BC  et al. (2001) Oral contraceptives and the risk of myocardial infarction. N Engl J Med 345: 1787\u20131793","journal-title":"N Engl J Med"},{"key":"BFncprheum0484_CR22","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0010-7824(01)00306-7","volume":"65","author":"O Lidegaard","year":"2002","unstructured":"Lidegaard O and Kreiner S (2002) Contraceptives and cerebral thrombosis: a five-year national case\u2013control study. Contraception 65: 197\u2013205","journal-title":"Contraception"},{"key":"BFncprheum0484_CR23","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1056\/NEJM199607043350102","volume":"335","author":"DB Pettiti","year":"1996","unstructured":"Pettiti DB  et al. (1996) Stroke in users of low dose contraceptives. N Engl J Med 335: 8\u201315","journal-title":"N Engl J Med"},{"key":"BFncprheum0484_CR24","doi-asserted-by":"crossref","unstructured":"World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception (1997) Acute myocardial infarction and combined oral contraceptives: results of an international, multicentre, case\u2013control study. Lancet 349: 1202\u20131209","DOI":"10.1016\/S0140-6736(97)02358-1"},{"key":"BFncprheum0484_CR25","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1046\/j.1538-7836.2003.00079.x","volume":"1","author":"MA Van den Bosch","year":"2003","unstructured":"Van den Bosch MA  et al. (2003) The RATIO study: oral contraceptives and the risk of peripheral arterial disease in young women. J Thromb Haemost 1: 439\u2013444","journal-title":"J Thromb Haemost"},{"key":"BFncprheum0484_CR26","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1001\/archinte.160.1.49","volume":"160","author":"KWM Bloemenkamp","year":"2000","unstructured":"Bloemenkamp KWM  et al. (2000) Higher risk of venous thrombosis during early use of oral contraceptives in women with inherited clotting defects. Arch Intern Med 160: 49\u201352","journal-title":"Arch Intern Med"},{"key":"BFncprheum0484_CR27","first-page":"735","volume":"86","author":"R Forastiero","year":"2001","unstructured":"Forastiero R  et al. (2001) The combination of thrombophilic genotypes is associated with definite antiphospholipid syndrome. Haematologica 86: 735\u2013741","journal-title":"Haematologica"},{"key":"BFncprheum0484_CR28","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1182\/blood-2003-11-4085","volume":"104","author":"JL Brouwer","year":"2004","unstructured":"Brouwer JL  et al. (2004) The contribution of inherited and acquired thrombophilic defects, alone or combined with antiphospholipid antibodies, to venous and arterial thromboembolism in patients with systemic lupus erythematosus. Blood 104: 143\u2013148","journal-title":"Blood"},{"key":"BFncprheum0484_CR29","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1097\/00001721-199606000-00011","volume":"7","author":"A Girolami","year":"1996","unstructured":"Girolami A  et al. (1996) Thromboembolic disease developing during oral contraceptive therapy in young females with antiphospholipid antibodies. Blood Coagul Fibrinolysis 7: 497\u2013501","journal-title":"Blood Coagul Fibrinolysis"},{"key":"BFncprheum0484_CR30","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1056\/NEJMoa051135","volume":"353","author":"M Petri","year":"2005","unstructured":"Petri M  et al. (2005) Combined oral contraceptives in women with systemic lupus erythematosus. N Engl J Med 353: 2550\u20132558","journal-title":"N Engl J Med"},{"key":"BFncprheum0484_CR31","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1056\/NEJMoa050817","volume":"353","author":"J Sanchez-Guerrero","year":"2005","unstructured":"Sanchez-Guerrero J  et al. (2005) A trial of contraceptive methods in women with systemic lupus erythematosus. N Engl J Med 353: 2539\u20132549","journal-title":"N Engl J Med"},{"key":"BFncprheum0484_CR32","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1016\/j.ajog.2005.05.002","volume":"193","author":"ZE Schaedel","year":"2005","unstructured":"Schaedel ZE  et al. (2005) The use of the levonorgestrel-releasing intrauterine system in the management of menorrhagia in women with hemostatic disorders. Am J Obstet Gynecol 193: 1361\u20131363","journal-title":"Am J Obstet Gynecol"},{"key":"BFncprheum0484_CR33","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1002\/art.1780221106","volume":"22","author":"RG Lahita","year":"1979","unstructured":"Lahita RG  et al. (1979) Alterations of estrogen metabolism in systemic lupus erythematosus. Arthritis Rheum 22: 1195\u20131198","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0484_CR34","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1002\/art.1780231213","volume":"23","author":"M Garovich","year":"1980","unstructured":"Garovich M  et al. (1980) Oral contraceptives and systemic lupus. Arthritis Rheum 23: 1396\u20131398","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0484_CR35","first-page":"531","volume":"121","author":"S Ansar Ahmend","year":"1985","unstructured":"Ansar Ahmend S  et al. (1985) Sex hormones, immune responses, and autoimmune diseases. Mechanisms of sex hormone action. Am J Pathol 121: 531\u2013551","journal-title":"Am J Pathol"},{"key":"BFncprheum0484_CR36","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1002\/art.1780400505","volume":"40","author":"J Sanchez-Guerrero","year":"1997","unstructured":"Sanchez-Guerrero J  et al. (1997) Past use of oral contraceptives and the risk of developing systemic lupus erythematosus. Arthritis Rheum 40: 804\u2013808","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0484_CR37","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1002\/art.10365","volume":"46","author":"GS Cooper","year":"2002","unstructured":"Cooper GS  et al. (2002) Hormonal and reproductive risk factors for development of systemic lupus erythematosus: results of a population based, case-control study. Arthritis Rheum 46: 1830\u20131839","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0484_CR38","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1093\/rheumatology\/41.5.563","volume":"41","author":"AA Bengtsson","year":"2002","unstructured":"Bengtsson AA  et al. (2002) Risk factors for developing systemic lupus erythematosus: a case-control study in southern Sweden. Rheumatology (Oxford) 41: 563\u2013571","journal-title":"Rheumatology (Oxford)"},{"key":"BFncprheum0484_CR39","doi-asserted-by":"publisher","first-page":"427","DOI":"10.3109\/03009749109096822","volume":"20","author":"HA Julkunen","year":"1991","unstructured":"Julkunen HA (1991) Oral contraceptives in systemic lupus erythematosus: side effects and influence on the activity of SLE. Scand J Rheumatol 20: 427\u2013433","journal-title":"Scand J Rheumatol"},{"key":"BFncprheum0484_CR40","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1002\/art.1780250603","volume":"25","author":"P Jungers","year":"1982","unstructured":"Jungers P  et al. (1982) Influence of oral contraceptive therapy on the activity of systemic lupus erythematosus. Arthritis Rheum 25: 618\u2013623","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0484_CR41","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/0010-7824(84)90076-3","volume":"30","author":"G Mintz","year":"1984","unstructured":"Mintz G  et al. (1984) Contraception with progestagens in systemic lupus erythematosus. Contraception 30: 29\u201338","journal-title":"Contraception"},{"key":"BFncprheum0484_CR42","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/00124743-199508000-00002","volume":"1","author":"JP Buyon","year":"1995","unstructured":"Buyon JP  et al. (1995) Can women with systemic lupus erythematosus safely use exogenous estrogens? J Clin Rheumatol 1: 205\u2013212","journal-title":"J Clin Rheumatol"},{"key":"BFncprheum0484_CR43","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1002\/art.1780260915","volume":"26","author":"M Ostensen","year":"1983","unstructured":"Ostensen M and Husby G (1983) A prospective study of the effect of pregnancy on rheumatoid arthritis and ankylosing spondylitis. Arthritis Rheum 26: 1155\u20131159","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0484_CR44","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/0895-4356(90)90023-I","volume":"43","author":"TD Spector","year":"1990","unstructured":"Spector TD and Hochberg MC (1990) The protective effect of the oral contraceptive pill on rheumatoid arthritis: an overview of the analytic studies using meta-analysis. J Clin Epidemol 43: 1221\u20131230","journal-title":"J Clin Epidemol"},{"key":"BFncprheum0484_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/oxfordjournals.aje.a008846","volume":"144","author":"M Pladevall-Vila","year":"1996","unstructured":"Pladevall-Vila M  et al. (1996) Controversy of oral contraceptives and risk of rheumatoid arthritis: meta-analysis of conflicting studies and review of conflicting meta-analysis with special emphasis on analysis of heterogeneity. Am J Epidemiol 144: 1\u201314","journal-title":"Am J Epidemiol"},{"key":"BFncprheum0484_CR46","unstructured":"Anonymous (1978) Reduction in incidence of rheumatoid arthritis associated with oral contraceptives. Royal College of General Practitioners' Oral Contraception Study. Lancet 1: 569\u2013571"},{"key":"BFncprheum0484_CR47","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1002\/art.1780330604","volume":"33","author":"TD Spector","year":"1990","unstructured":"Spector TD  et al. (1990) The pill, parity, and rheumatoid arthritis. Arthritis Rheum 33: 782\u2013789","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0484_CR48","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1136\/ard.55.2.94","volume":"55","author":"C Jorgensen","year":"1996","unstructured":"Jorgensen C  et al. (1996) Oral contraception, parity, breast feeding, and severity of rheumatoid arthritis. Ann Rheum Dis 55: 94\u201398","journal-title":"Ann Rheum Dis"},{"key":"BFncprheum0484_CR49","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1002\/art.1780330705","volume":"33","author":"M Hernandez-Avila","year":"1990","unstructured":"Hernandez-Avila M  et al. (1990) Exogenous sex hormones and the risk of rheumatoid arthritis. Arthritis Rheum 33: 947\u2013953","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0484_CR50","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/j.1749-6632.2002.tb04210.x","volume":"966","author":"M Cutolo","year":"2002","unstructured":"Cutolo M  et al. (2002) Androgens and estrogens modulate the immune and inflammatory responses in rheumatoid arthritis. Ann NY Acad Sci 966: 131\u2013142","journal-title":"Ann NY Acad Sci"},{"key":"BFncprheum0484_CR51","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1136\/ard.55.11.811","volume":"55","author":"A Booij","year":"1996","unstructured":"Booij A  et al. (1996) Androgens as adjuvant treatment in postmenopausal patients with rheumatoid arthritis. Ann Rheum Dis 55: 811\u2013815","journal-title":"Ann Rheum Dis"},{"key":"BFncprheum0484_CR52","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1136\/ard.53.2.112","volume":"53","author":"GM Hall","year":"1994","unstructured":"Hall GM  et al. (1994) A randomized controlled trial of the effect of hormone replacement therapy on disease activity in postmenopausal RA. Ann Rheum Dis 53: 112\u2013116","journal-title":"Ann Rheum Dis"},{"key":"BFncprheum0484_CR53","first-page":"421","volume":"14","author":"J Lekakis","year":"1996","unstructured":"Lekakis J  et al. (1996) Acute estrogen administration can reverse cold-induced coronary Raynaud's phenomenon in systemic sclerosis. Clin Exp Rheumatol 14: 421\u2013424","journal-title":"Clin Exp Rheumatol"},{"key":"BFncprheum0484_CR54","first-page":"309","volume":"11","author":"ML Bartelink","year":"1992","unstructured":"Bartelink ML  et al. (1992) Raynaud's phenomenon: subjective influence of female sex hormones. Int Angiol 11: 309\u2013315","journal-title":"Int Angiol"},{"key":"BFncprheum0484_CR55","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1016\/0002-9378(90)90556-M","volume":"163","author":"K Fotherby","year":"1990","unstructured":"Fotherby K (1990) Interactions with oral contraceptives. Am J Obstet Gynecol 163: 2153\u20132159","journal-title":"Am J Obstet Gynecol"},{"key":"BFncprheum0484_CR56","volume-title":"Contraceptive Technology","author":"J Trussell","year":"2004","unstructured":"Trussell J (2004) Contraceptive Efficacy. In: Contraceptive Technology, edn 18 (Eds Hatcher RA  et al.) New York: Ardent Media"},{"key":"BFncprheum0484_CR57","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1067\/mjd.2002.120448","volume":"46","author":"JSM Archer","year":"2002","unstructured":"Archer JSM and Archer DF (2002) Oral contraceptive efficacy and antibiotic interaction: a myth debunked. J Am Acad Dermatol 46: 917\u2013923","journal-title":"J Am Acad Dermatol"}],"container-title":["Nature Clinical Practice Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ncprheum0484.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncprheum0484","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncprheum0484.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T21:04:51Z","timestamp":1684443891000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncprheum0484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":57,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["BFncprheum0484"],"URL":"https:\/\/doi.org\/10.1038\/ncprheum0484","relation":{},"ISSN":["1745-8382","1745-8390"],"issn-type":[{"value":"1745-8382","type":"print"},{"value":"1745-8390","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,5]]}}}